Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

Q1 2026 13F · SEC CIK 1047859

Paragon Associates & Paragon Associates II Joint Venture

Venture capitalFiled 2026-05-15 for Q1 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value
$73.6M
Reported positions
14
Top holdings a year, 3 yrs
+33.8%
Average holding period
2.6 yrs

Paragon Associates & Paragon Associates II Joint Venture is a venture capital that reported 14 positions worth $73.6M in its Q1 2026 13F, filed 2026-05-15. Its largest holdings were Coeur Mng Inc (CDE, 16.6%), State Str Spdr S&p 500 ETF T (SPY, 13.3%), CareDx, Inc. (CDNA, 11.8%). A portfolio copying its top holdings returned 33.8% a year over the last 3 years, against 20.4% for the S&P 500.

Paragon Associates & Paragon Associates II Joint Venture holdings all 14 positions.

Weights are shares of the filer's total reported 13F value, compared with Q4 2025. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Paragon Associates & Paragon Associates II Joint Venture 13F holdings
Stock% of 13F valueShare changeReported value
CDECoeur Mng Inc16.6%—$12.2M
SPYState Str Spdr S&p 500 ETF T13.3%—$9.8M
CDNACareDx, Inc.11.8%+33.3%$8.7M
DMACDiamedica Therapeutics Inc8.1%+0.0%$5.9M
NVGSNavigator Holdings PLC7.9%+0.0%$5.8M
NPKINpk International Inc7.4%-6.3%$5.4M
STKLSunopta Inc7.1%+0.5%$5.2M
AEMAgnico Eagle Mines Ltd6.9%-49.9%$5.1M
WESWestern Midstream Partners LP5.6%—$4.1M
EPSNEpsilon Energy Ltd5.4%+0.0%$4.0M
IAUXI-80 Gold Corp5.2%+66.7%$3.8M
PROFProfound Med Corp2.4%—$1.8M
IRIXIridex Corp1.4%+0.0%$1.0M
NEXMNexmetals Mining Corp.1.1%—$796K

What Paragon Associates & Paragon Associates II Joint Venture bought and sold in Q1 2026, against Q4 2025.

Share counts compared with the Q4 2025 13F; a split also changes share counts.

How the holdings did against the S&P 500.

1 year
+59.8% /yr
S&P 500 +20.1%
3 years
+33.8% /yr
S&P 500 +20.4%
5 years
+20.0% /yr
S&P 500 +11.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter13F valuePositions
Q1 2026$73.6M14
Q4 2025$48.4M12
Q3 2025$56.1M12
Q2 2025$63.0M15
Q1 2025$42.7M13
Q4 2024$43.2M12
Q3 2024$55.7M16
Q2 2024$40.9M11
Q1 2024$56.1M16
Q4 2023$43.6M15
Q3 2023$30.5M10
Q2 2023$48.9M13

Questions about Paragon Associates & Paragon Associates II Joint Venture's portfolio

What stocks does Paragon Associates & Paragon Associates II Joint Venture own?

Paragon Associates & Paragon Associates II Joint Venture's latest 13F, for Q1 2026 and filed May 15, 2026, lists 14 positions worth $73.6M. The largest are Coeur Mng Inc (CDE) at 16.6%, State Str Spdr S&p 500 ETF T (SPY) at 13.3%, CareDx, Inc. (CDNA) at 11.8%, Diamedica Therapeutics Inc (DMAC) at 8.1% and Navigator Holdings PLC (NVGS) at 7.9%.

What did Paragon Associates & Paragon Associates II Joint Venture buy last quarter?

In Q1 2026, Paragon Associates & Paragon Associates II Joint Venture added a new position in Coeur Mng Inc (CDE), a new position in State Str Spdr S&p 500 ETF T (SPY), a new position in Western Midstream Partners LP (WES), a new position in Profound Med Corp (PROF), a new position in Nexmetals Mining Corp. (NEXM), I-80 Gold Corp (IAUX) (+66.7% shares) and CareDx, Inc. (CDNA) (+33.3% shares), compared with its Q4 2025 filing.

What did Paragon Associates & Paragon Associates II Joint Venture sell last quarter?

In Q1 2026, Paragon Associates & Paragon Associates II Joint Venture sold all of Invesco Qqq Tr (QQQ), sold all of Bel Fuse Inc. - Class B Common Stock (BELFB), sold all of Quanterix Corp (QTRX), Agnico Eagle Mines Ltd (AEM) (-49.9% shares) and Npk International Inc (NPKI) (-6.3% shares), compared with its Q4 2025 filing.

How has Paragon Associates & Paragon Associates II Joint Venture's portfolio performed?

A portfolio copying Paragon Associates & Paragon Associates II Joint Venture's 20 largest 13F holdings each quarter, from the day each filing was public, returned +33.8% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +59.8% against +20.1%. Over 5 years: +20.0% a year against +11.6%.

When is Paragon Associates & Paragon Associates II Joint Venture's next 13F filing due?

13F filings are due 45 days after each quarter ends. Paragon Associates & Paragon Associates II Joint Venture's filing for the quarter ending Jun 30, 2026 was due by Aug 14, 2026; this page updates once it is processed.